- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: 89Zr-pertuzumab
Total 571 results
-
Emory UniversityTerminated
-
Janssen Pharmaceutical K.K.RecruitingTreatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)Taiwan, Korea, Republic of, Japan
-
NovartisCompletedHypertensionGermany, Switzerland
-
Boehringer IngelheimCompletedBreast NeoplasmsSpain, United States, Belgium, Italy, Germany, France, Greece, United Kingdom, Portugal, Australia, Canada
-
Second Affiliated Hospital, School of Medicine,...Recruiting
-
The University of New South WalesCompletedMyelodysplastic Syndromes | LeukemiaUnited Kingdom
-
St. Jude Children's Research HospitalAbbVieRecruitingAcute Myeloid LeukemiaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Canada, Australia, Switzerland, New Zealand, Puerto Rico
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAcute Promyelocytic Leukemia With PML-RARAUnited States
-
Second Affiliated Hospital, School of Medicine,...Recruiting
-
Derrick Scott RobertsonUniversity of South Florida; Genzyme, a Sanofi CompanyTerminatedHealthy Volunteers | Teriflunomide EliminationUnited States
-
PfizerVicuron PharmaceuticalsCompleted
-
Shanghai Pudong HospitalCSPC Ouyi Pharmaceutical Co., Ltd.Recruiting
-
Yale UniversityGenentech, Inc.CompletedHer2-Positive Breast CancerUnited States
-
Hoffmann-La RocheCompletedBreast CancerUnited States, Canada, Denmark, France, Italy, Poland, Portugal, Spain, United Kingdom, Norway, Germany, Mexico
-
University of ChicagoWithdrawnBreast Cancer | Breast Cancer Stage II | Breast Cancer Stage IIINigeria
-
Boehringer IngelheimCompleted
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Canada, Australia, Puerto Rico, Switzerland
-
Acute Leukemia French AssociationVersailles HospitalCompleted
-
AstraZenecaDaiichi SankyoActive, not recruitingBreast Cancer | Breast Neoplasms | HER2-positive Early Breast CancerUnited States, Italy, Spain, Poland, Taiwan, Thailand, Canada, Germany, Korea, Republic of, Brazil, India, Japan, Peru, Philippines, China, Saudi Arabia, Russian Federation, Bulgaria
-
Western Regional Medical CenterTerminated
-
Hoffmann-La RocheGenentech, Inc.; Breast International GroupActive, not recruitingBreast CancerUnited States, Belgium, Canada, Australia, Austria, Bulgaria, China, Croatia, Denmark, France, Germany, Guatemala, Hungary, Ireland, Italy, Korea, Republic of, Panama, Slovenia, Spain, Taiwan, United Kingdom, Colombia, Czechia, El Salvador and more
-
Sun Yat-sen UniversityFirst Affiliated Hospital, Sun Yat-Sen University; Sun Yat-Sen Memorial Hospital...Active, not recruitingBreast Cancer | Neoadjuvant ChemotherapyChina
-
The Netherlands Cancer InstituteBristol-Myers Squibb; Eli Lilly and Company; Bayer; GlaxoSmithKline; Merck Sharp... and other collaboratorsRecruitingCancer | Neoplasm | Tumors | NeoplasiaNetherlands
-
German Breast GroupRoche Pharma AG; Amgen; Teva Pharmaceuticals USA; Vifor PharmaCompletedInflammatory Breast Cancer | HER2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage IIIGermany
-
Hoffmann-La RocheFoundation Medicine, Inc.Active, not recruitingCancer of Unknown Primary SiteUnited Kingdom, Korea, Republic of, France, Australia, Germany, Austria, Croatia, Denmark, Finland, Greece, Hungary, Italy, Portugal, Spain, Japan, Brazil, Colombia, Mexico, Romania, Czechia, Norway, Thailand, Switzerland, Turkey, Nethe... and more
-
Fondazione MichelangeloHoffmann-La RocheActive, not recruitingInvasive Breast CancerSpain, Italy, Germany, Austria
-
German Breast GroupCelgene Corporation; AmgenCompletedInflammatory Breast Cancer | HER2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage IIIGermany
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | High Risk Myelodysplastic Syndrome | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Philadelphia Chromosome Positive | Myeloproliferative Neoplasm | Myeloid Sarcoma | Blasts 10 Percent or More of Bone Marrow Nucleated CellsUnited States
-
Hoffmann-La RocheCompletedColorectal CancerItaly, Korea, Republic of, United Kingdom, Belgium, Argentina, Denmark, Greece, Netherlands, Slovenia, Spain, Sweden, Turkey, Brazil, Bosnia and Herzegovina, France, Germany, Portugal, Egypt, Poland, Slovakia, Mexico, Serbia, Russian...
-
Hoffmann-La RocheCompletedBreast CancerUnited States, France, Czechia, Italy, Korea, Republic of, Australia, Belgium, Brazil, Canada, Germany, Guatemala, Hong Kong, Hungary, Panama, Peru, Poland, Spain, Taiwan, United Kingdom, Colombia, Bosnia and Herzegovina, Chile, El... and more
-
Hoffmann-La RocheChugai PharmaceuticalCompletedBreast CancerKorea, Republic of, Canada, Brazil, Germany, Italy, Spain, Japan, Czechia, Poland, United States, Russian Federation, Taiwan
-
Renske AltenaTerminatedHER2-positive Breast Cancer | Early-stage Breast CancerSweden
-
Hoffmann-La RocheCompletedHER2-Positive Metastatic Breast Cancer | HER2-Negative Metastatic Breast Cancer | Locally Advanced or Early Breast CancerUnited States
-
PfizerCompletedInvasive CandidiasisCzech Republic, Belgium, Austria, Portugal, Russian Federation, Turkey, Canada, Germany, Italy, United Kingdom, Hungary, France, Slovakia, Denmark, Romania, Netherlands, Poland, Greece, Ukraine
-
Eli Lilly and CompanyActive, not recruitingBreast NeoplasmsUnited States
-
Massachusetts General HospitalCompletedAttention Deficit Hyperactivity Disorder | Deficient Emotional Self-RegulationUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingUntreated Adult Acute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts | High Risk Myelodysplastic Syndrome | de Novo Myelodysplastic Syndrome | Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1 | Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 | Acute Myeloid... and other conditionsUnited States
-
Uma BorateSuspended
-
Fred Hutchinson Cancer CenterPfizerCompletedAcute Myeloid LeukemiaUnited States
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI)CompletedLeukemia, Myelocytic, AcuteUnited States
-
Karolinska University HospitalRecruiting
-
OHSU Knight Cancer InstituteGenentech, Inc.; Oregon Health and Science UniversityWithdrawnAnatomic Stage III Breast Cancer AJCC v8 | Recurrent Ovarian Carcinoma | Anatomic Stage IV Breast Cancer AJCC v8 | Advanced Malignant Solid Neoplasm | Advanced Pancreatic Carcinoma | Stage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Recurrent... and other conditionsUnited States
-
First Affiliated Hospital Xi'an Jiaotong UniversityRecruiting
-
Prisma Health-MidlandsCompletedAnkle Fractures | Bunion of Unspecified Foot | Bunionette of Unspecified Foot | Hammertoe | Achilles Tendon SurgeryUnited States
-
Aalborg UniversityUnknown
-
Cardiff UniversityCancer Research UKUnknownMyelodysplastic Syndrome | Acute Myeloid LeukaemiaDenmark, United Kingdom
-
M.D. Anderson Cancer CenterTerminatedLeukemia | Pediatric CancerUnited States
-
Fondazione per la Medicina PersonalizzataActive, not recruitingBreast Cancer | Non Small Cell Lung Cancer | Gastrointestinal Cancer | Other CancerItaly
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)RecruitingStage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Breast AdenocarcinomaUnited States